High surface area polypyrrole scaffolds for tunable drug delivery

Intrinsically conducting polymers such as polypyrrole (PPy) are viable platforms for efficient drug delivery, where release rates can be tuned by external electrical stimulus. In this study, the successful fabrication of 3-dimensionally ordered macroporous PPy inverse opal thin films is described, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2013-02, Vol.443 (1-2), p.163-168
Hauptverfasser: Sharma, Manisha, Waterhouse, Geoffrey I.N., Loader, Samuel W.C., Garg, Sanjay, Svirskis, Darren
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Intrinsically conducting polymers such as polypyrrole (PPy) are viable platforms for efficient drug delivery, where release rates can be tuned by external electrical stimulus. In this study, the successful fabrication of 3-dimensionally ordered macroporous PPy inverse opal thin films is described, and the viability of such films for controlled drug release evaluated in vitro. The PPy inverse opal thin films were obtained by electropolymerization of PPy through the interstitial voids of a colloidal crystal template composed of poly(methyl methacrylate) colloids of diameter ∼430nm. Chemical etching of the template yielded macroporous PPy inverse opal scaffolds. The model drug risperidone was loaded into the PPy inverse opal films, and then entrapped by electropolymerization of a non-porous PPy overlayer. The morphology and chemical composition of the PPy scaffolds were evaluated by SEM and FTIR spectroscopy, respectively. The high surface area PPy inverse opal scaffolds exhibited enhanced drug loading and releasing capabilities compared to conventional non-porous PPy films. Drug release profiles could be modified by applying electrical stimulus, which caused actuation of the porous polypyrrole films. The proposed delivery system may find use as an implantable device where drug release can be electrically tuned according to patient requirements.
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2013.01.006